0001493152-23-005412.txt : 20230217 0001493152-23-005412.hdr.sgml : 20230217 20230217151502 ACCESSION NUMBER: 0001493152-23-005412 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bentovim Lyron L CENTRAL INDEX KEY: 0001326879 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40556 FILM NUMBER: 23642097 MAIL ADDRESS: STREET 1: 60 CUTTER MILL ROAD STREET 2: GREAT NECK CITY: NEW YORK STATE: NY ZIP: 11021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Glimpse Group, Inc. CENTRAL INDEX KEY: 0001854445 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371] IRS NUMBER: 812958271 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 15 WEST 38TH ST, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 917-292-2685 MAIL ADDRESS: STREET 1: 15 WEST 38TH ST, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 4 1 ownership.xml X0306 4 2023-02-15 0 0001854445 Glimpse Group, Inc. VRAR 0001326879 Bentovim Lyron L 15 WEST 38TH ST, 12TH FLOOR NEW YORK NY 10018 1 1 0 0 Chief Executive Officer Stock Options (right to buy) 7.00 2023-02-15 4 A 0 1210000 0 A 2023-02-15 2033-02-15 Common Stock 1210000 1210000 D On February 15, 2023, the Company, under its 2016 Incentive Plan, issued to Mr. Bentovim options (the "Options") to purchase 1,210,000 shares of Common Stock, subject to the terms and conditions of Mr. Bentovim's Options Agreement, which include certain provisions set for in the Remarks section below. The beneficial ownership set forth above does not include 37,224 shares directly held by Mr. Bentovim, 90,188 options to purchase common stock held by Mr. Bentovim, as well as 1,001,945 shares indirectly held by Mr. Bentovim (through Darklight Partners LLC - an entity owned and managed by Mr. Bentovim). (i) an exercise price equal to $7.00 per share of Common Stock; (ii) expiration of the Options on the Tenth (10) anniversary of the Grant Date; (iii) all Options to vest over four (4) years commencing on February 15, 2023; (iv) certain Options shall vest in fixed amounts, based on achieving revenue targets of $30,000,000, $50,000,000, $75,000,000 and $100,000,000 over consecutive four quarter periods in the aggregate over the next 7 years; and (v) certain Options shall vest to each grantee in fixed amounts, based on achieving fifteen consecutive closing trading priced equal to or above $20, $30, $45 and $60 per share over the next 7 years. /s/ Lyron Bentovim 2023-02-17